Calcifediol [kalcifediol]
- Terms
-
25-hydroxyvitamin D3
hydroxycholekalciferol
kalcidiol
Uperold
-
25-Hydroxycholecalciferol
25-Hydroxycholecalciferol Monohydrate
25-Hydroxyvitamin D 3
25-Hydroxyvitamin D3
Calcidiol
Calcifediol Anhydrous
Calcifediol, (3 alpha,5Z,7E)-Isomer
Calcifediol, (3 beta,5E,7E)-Isomer
Calderol
Dedrogyl
Hidroferol
The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties.
- Annotation
- deficiency: coordinate CALCIFEDIOL /defic (IM) with VITAMIN D DEFICIENCY (IM)
- nedostatek: kombinuj deskriptory KALCIFEDIOL s podheslem /nedostatek (IM) a NEDOSTATEK VITAMINU D (IM)
- DUI
- D002112 MeSH Browser
- CUI
- M0003141
- CAS
- 9,10-Secocholesta-5,7,10(19)-triene-3,25-diol, (3beta,5Z,7E)-
- Previous indexing
- Cholecalciferols (1966-1972); Hydroxycholecalciferols (1972-1982)
- History note
- 83
- Public note
- 83
Allowable subheadings
- AD
- administration & dosage 5
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis 5
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood 36
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DF
- deficiency 4
- EC
- economics
- GE
- genetics 1
- HI
- history
- IM
- immunology
- IP
- isolation & purification 1
- ME
- metabolism 7
- PK
- pharmacokinetics
- PD
- pharmacology 2
- PH
- physiology 2
- PO
- poisoning
- RE
- radiation effects 1
- ST
- standards 4
- SD
- supply & distribution
- TU
- therapeutic use 1
- TO
- toxicity
- UR
- urine